anti-IL-11 monoclonal antibody 9MW3811
Term · Oncology and biomedicine · MLC-T-ONC-010810
A humanized monoclonal antibody directed against interleukin-11 (IL-11), with potential anti-fibrotic and antineoplastic activities. Upon administration, anti-IL-11 monoclonal antibody 9MW3811 targets and binds to IL-11. This prevents the binding of IL-11 to interleukin-11 receptor subunit alpha (IL-11RA), and inhibits IL-11-mediated signaling via the gp130/IL-11RA receptor complex. This may decrease fibrosis and inhibit tumor cell proliferation. IL-11, a member of the IL-6 family of cytokines, is upregulated in some fibro-inflammatory diseases and cancers.
| Identifier | MLC-T-ONC-010810 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010810",
"term": "anti-IL-11 monoclonal antibody 9MW3811",
"field": "Oncology and biomedicine",
"definition": "A humanized monoclonal antibody directed against interleukin-11 (IL-11), with potential anti-fibrotic and antineoplastic activities. Upon administration, anti-IL-11 monoclonal antibody 9MW3811 targets and binds to IL-11. This prevents the binding of IL-11 to interleukin-11 receptor subunit alpha (IL-11RA), and inhibits IL-11-mediated signaling via the gp130/IL-11RA receptor complex. This may decrease fibrosis and inhibit tumor cell proliferation. IL-11, a member of the IL-6 family of cytokines, is upregulated in some fibro-inflammatory diseases and cancers.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-il-11-monoclonal-antibody-9mw3811/"
}
Record 1,924 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.